Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay
Zofia M. Komar
Nicole S. Verkaik
Ahmed Dahmani
Elodie Montaudon
Roland Kanaar
Adriaan B. Houtsmuller
Agnes Jager
Elisabetta Marangoni
Dik C. van Gent
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41523-025-00734-x
Feb 17, 2025
Version published to 10.21203/rs.3.rs-4873503/v1 on Research Square
Sep 18, 2024
Related articles
Clinical-Preclinical Connections Solidified the Foundation Supporting PRMT5 as a Reliable Lymphoma Prognosis Biomarker
This article has 5 authors:
Yuxuan Che
Yi Liu
Mohamed Ziyaau
Xiuhua Sun
Man Li
Molecular Subtyping of Early-Stage Osteosarcoma: Identifying Resistance and Optimizing Therapy
This article has 6 authors:
Luka Bojic
Mina Peric
Jelena Karanovic
Emilija Milosevic
Natasa Kovacevic Grujicic
Milena Milivojevic
EXOSC5: A Novel Biomarker for Poor Prognosis in Lung Adenocarcinoma
This article has 5 authors:
Jianxun Xu
Zhengwei Zhang
Keyao Han
Zhen Yang
Fengmei Guo
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up